Suppr超能文献

相似文献

2
Message Transmission Between Adipocyte and Macrophage in Obesity.
Adv Exp Med Biol. 2024;1460:273-295. doi: 10.1007/978-3-031-63657-8_9.
3
Adipocyte-Macrophage Cross-Talk in Obesity.
Adv Exp Med Biol. 2017;960:327-343. doi: 10.1007/978-3-319-48382-5_14.
5
The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis.
J Hepatol. 2021 Aug;75(2):387-399. doi: 10.1016/j.jhep.2021.03.006. Epub 2021 Mar 18.
6
Acute activation of adipocyte lipolysis reveals dynamic lipid remodeling of the hepatic lipidome.
J Lipid Res. 2024 Feb;65(2):100434. doi: 10.1016/j.jlr.2023.100434. Epub 2023 Aug 26.
8
Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.
Adv Exp Med Biol. 2024;1460:97-129. doi: 10.1007/978-3-031-63657-8_4.
9
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Liver Int. 2009 Aug;29(7):988-96. doi: 10.1111/j.1478-3231.2009.02006.x. Epub 2009 Apr 6.
10
Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.
Am J Physiol Gastrointest Liver Physiol. 2021 Sep 1;321(3):G298-G307. doi: 10.1152/ajpgi.00458.2020. Epub 2021 Jul 14.

引用本文的文献

2
Inflammation in MASLD progression and cancer.
JHEP Rep. 2025 Apr 2;7(8):101414. doi: 10.1016/j.jhepr.2025.101414. eCollection 2025 Aug.
3
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD.
Biomedicines. 2025 Feb 6;13(2):393. doi: 10.3390/biomedicines13020393.
4
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease.
Liver Res. 2022 Jul 1;7(1):16-25. doi: 10.1016/j.livres.2022.06.001. eCollection 2023 Mar.
5
Reply to correspondence 1 on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".
Clin Mol Hepatol. 2025 Apr;31(2):e226-e227. doi: 10.3350/cmh.2025.0128. Epub 2025 Feb 13.
7
Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK/AP-1 signaling cascade and ROS production in hepatocytes.
Toxicol Res. 2024 Sep 27;41(1):47-59. doi: 10.1007/s43188-024-00263-y. eCollection 2025 Jan.
8
Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment.
Biomedicines. 2024 Aug 16;12(8):1876. doi: 10.3390/biomedicines12081876.
9
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives.
Clin Mol Hepatol. 2024 Oct;30(4):620-648. doi: 10.3350/cmh.2024.0315. Epub 2024 Jul 11.

本文引用的文献

3
SNAP23 regulates BAX-dependent adipocyte programmed cell death independently of canonical macroautophagy.
J Clin Invest. 2018 Aug 31;128(9):3941-3956. doi: 10.1172/JCI99217. Epub 2018 Aug 13.
4
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol. 2018 Apr 1;314(4):G483-G493. doi: 10.1152/ajpgi.00213.2017. Epub 2018 Feb 8.
5
Take me to the liver: adipose tissue macrophages coordinate hepatic neutrophil recruitment.
Gut. 2018 Jul;67(7):1204-1206. doi: 10.1136/gutjnl-2017-315393. Epub 2018 Jan 3.
7
Therapy for steatohepatitis: Do macrophages hold the clue?
Hepatology. 2018 Apr;67(4):1204-1206. doi: 10.1002/hep.29630. Epub 2018 Feb 19.
8
Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice.
Gut. 2018 Jul;67(7):1317-1327. doi: 10.1136/gutjnl-2016-313654. Epub 2017 Oct 26.
9
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Hepatology. 2018 Apr;67(4):1270-1283. doi: 10.1002/hep.29544. Epub 2018 Feb 19.
10
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations.
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):50-59. doi: 10.1038/nrgastro.2017.116. Epub 2017 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验